News
11h
allAfrica.com on MSNSA gets R520m to buy the twice-a-year anti-HIV jab... but there’s a snagSouth Africa has accepted an offer of just over $29 million (about R520 million) from the Global Fund to Fight Aids, TB and ...
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...
Both Mashatile and Motsoaledi have repeatedly lamented, correctly, the severe reliance of our health system on external donors, but have not acknowledged that they have been fully responsible for the ...
21h
AllAfrica on MSNMomentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To ActionNew WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...
A larger role for China, perhaps, and the fraught issue of integrating HIV services into services for other diseases.
Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...
According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...
2h
The New Times on MSNWHO-approved test panel for HIV, Syphilis and Hepatitis B unveiled in KigaliA new rapid test panel for HIV, hepatitis B, and syphilis screening in pregnant women was unveiled at the International AIDS Society (IAS) Conference on HIV Science in Kigali on July 15. The test, ...
HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...
The rescissions package, a Trump Administration initiative under the Department of Government Efficiency (DOGE), aims to ...
Kevin Spacey, who was previously linked to financier Jeffrey Epstein amid speculation of a "client list," is weighing in on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results